Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1

Anissa M Jabbour1, Michelle A Puryer, Jai Y Yu

  • 1Children's Cancer Centre, Royal Children's Hospital, Parkville 3052, Australia.

Insights

Human Bcl-2 protein suppresses programmed cell death in nematodes by binding EGL-1, a key apoptosis regulator. This interaction prevents EGL-1 from inhibiting CED-9, clarifying Bcl-2

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • The anti-apoptotic function of Bcl-2 is crucial but its precise mechanism remains unclear.
  • Programmed cell death (apoptosis) is a fundamental biological process essential for development.
  • Caenorhabditis elegans provides a model system to study conserved apoptotic pathways.

Purpose of the Study:

  • To elucidate the molecular mechanism by which human Bcl-2 interacts with and regulates nematode cell death pathways.
  • To identify the specific nematode targets of Bcl-2's anti-apoptotic activity.
  • To understand how Bcl-2 functions within the conserved cell death machinery.

Main Methods:

  • Utilized yeast-based systems for biochemical assays.
  • Analyzed protein-protein interactions between Bcl-2 and nematode apoptosis regulators.
  • Investigated the functional consequences of Bcl-2 expression in a C. elegans model.

Main Results:

  • Human Bcl-2 expression reduced cell death during C. elegans development.
  • Bcl-2 did not directly bind or inhibit the caspase-activating adaptor CED-4.
  • Bcl-2 directly bound to the pro-apoptotic BH3-only protein EGL-1.

Conclusions:

  • Bcl-2 suppresses nematode cell death by interacting with EGL-1.
  • This interaction likely prevents EGL-1 from antagonizing the nematode Bcl-2 homolog, CED-9.
  • The findings suggest a conserved mechanism for Bcl-2's anti-apoptotic activity across species.